title: Fludarabine containing regimen followed by autologous peripheral blood stem cell transplantation in unselected patients with acute myeloid leukemia: a single center experience.
authors.forename: P
authors.initials: P
authors.lastname: Mazza
authors.forename: B
authors.initials: B
authors.lastname: Amurri
authors.forename: G
authors.initials: G
authors.lastname: Palazzo
authors.forename: A
authors.initials: A
authors.lastname: Prudenzano
authors.forename: G
authors.initials: G
authors.lastname: Pricolo
authors.forename: L
authors.initials: L
authors.lastname: Stani
mesh_terms: D000208:Acute Disease; D000293:Adolescent; D000328:Adult; D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage*; D003131:Combined Modality Therapy; D005260:Female; D019650:Hematopoietic Stem Cell Mobilization; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D007951:Leukemia, Myeloid / Q000628:therapy*; D008297:Male; D008875:Middle Aged; D014182:Transplantation, Autologous; D016896:Treatment Outcome; D014740:Vidarabine / Q000008:administration & dosage / Q000031:analogs & derivatives*
chemical_list: D014740:Vidarabine; C024352:fludarabine